Adjunctive versus monotherapeutic treatment for schizophrenia: addressing antipsychotic side effects
- PMID: 18316434
- DOI: 10.1176/appi.ajp.2007.07111738
Adjunctive versus monotherapeutic treatment for schizophrenia: addressing antipsychotic side effects
Comment on
-
Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial.Am J Psychiatry. 2007 Sep;164(9):1404-10. doi: 10.1176/appi.ajp.2007.06071075. Am J Psychiatry. 2007. PMID: 17728426 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
